UBcare. Co. Ltd (032620) - Net Assets
Based on the latest financial reports, UBcare. Co. Ltd (032620) has net assets worth ₩158.89 Billion KRW (≈ $107.68 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩227.70 Billion ≈ $154.31 Million USD) and total liabilities (₩68.81 Billion ≈ $46.63 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset resilience ratio of UBcare. Co. Ltd to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩158.89 Billion |
| % of Total Assets | 69.78% |
| Annual Growth Rate | 9.05% |
| 5-Year Change | 34.78% |
| 10-Year Change | 241.28% |
| Growth Volatility | 33.83 |
UBcare. Co. Ltd - Net Assets Trend (2011–2025)
This chart illustrates how UBcare. Co. Ltd's net assets have evolved over time, based on quarterly financial data. Also explore 032620 total assets for the complete picture of this company's asset base.
Annual Net Assets for UBcare. Co. Ltd (2011–2025)
The table below shows the annual net assets of UBcare. Co. Ltd from 2011 to 2025. For live valuation and market cap data, see UBcare. Co. Ltd (032620) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ₩158.89 Billion ≈ $107.68 Million |
+60.15% |
| 2024-12-31 | ₩99.22 Billion ≈ $67.24 Million |
-12.61% |
| 2023-12-31 | ₩113.54 Billion ≈ $76.94 Million |
-2.71% |
| 2022-12-31 | ₩116.70 Billion ≈ $79.09 Million |
-1.01% |
| 2021-12-31 | ₩117.89 Billion ≈ $79.89 Million |
+10.67% |
| 2020-12-31 | ₩106.52 Billion ≈ $72.19 Million |
+3.85% |
| 2019-12-31 | ₩102.57 Billion ≈ $69.51 Million |
+0.89% |
| 2018-12-31 | ₩101.66 Billion ≈ $68.90 Million |
+118.41% |
| 2017-12-31 | ₩46.55 Billion ≈ $31.55 Million |
-0.02% |
| 2016-12-31 | ₩46.56 Billion ≈ $31.55 Million |
+2.76% |
| 2015-12-31 | ₩45.31 Billion ≈ $30.70 Million |
+14.72% |
| 2014-12-31 | ₩39.49 Billion ≈ $26.76 Million |
-9.92% |
| 2013-12-31 | ₩43.84 Billion ≈ $29.71 Million |
-4.82% |
| 2012-12-31 | ₩46.07 Billion ≈ $31.22 Million |
-2.46% |
| 2011-12-31 | ₩47.23 Billion ≈ $32.01 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to UBcare. Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 7094936555000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩70.95 Billion | 50.12% |
| Other Components | ₩70.60 Billion | 49.88% |
| Total Equity | ₩141.55 Billion | 100.00% |
UBcare. Co. Ltd Competitors by Market Cap
The table below lists competitors of UBcare. Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
BriQ Properties Real Estate Investment Company
AT:BRIQ
|
$140.09 Million |
|
Innoviz Technologies
NASDAQ:INVZ
|
$140.09 Million |
|
PT Indonesia Kendaraan Terminal Tbk
JK:IPCC
|
$140.11 Million |
|
Uno&Company.Ltd
KQ:114630
|
$140.17 Million |
|
Multitude SE
LSE:0R4W
|
$139.98 Million |
|
Heidelberg Pharma AG
F:HPHA
|
$139.89 Million |
|
Syrah Resources Ltd
AU:SYR
|
$139.88 Million |
|
Venus Remedies Limited
NSE:VENUSREM
|
$139.85 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in UBcare. Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 99,215,352,930 to 141,545,775,050, a change of 42,330,422,120 (42.7%).
- Net income of 36,976,647,860 contributed positively to equity growth.
- Dividend payments of 1,522,279,260 reduced retained earnings.
- Other factors increased equity by 6,876,053,520.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩36.98 Billion | +26.12% |
| Dividends Paid | ₩1.52 Billion | -1.08% |
| Other Changes | ₩6.88 Billion | +4.86% |
| Total Change | ₩- | 42.67% |
Book Value vs Market Value Analysis
This analysis compares UBcare. Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.46x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 3.46x to 1.46x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩1174.26 | ₩4060.00 | x |
| 2017-12-31 | ₩1193.97 | ₩4060.00 | x |
| 2018-12-31 | ₩1980.14 | ₩4060.00 | x |
| 2019-12-31 | ₩2021.46 | ₩4060.00 | x |
| 2020-12-31 | ₩2099.31 | ₩4060.00 | x |
| 2021-12-31 | ₩2323.27 | ₩4060.00 | x |
| 2022-12-31 | ₩2299.84 | ₩4060.00 | x |
| 2023-12-31 | ₩2071.01 | ₩4060.00 | x |
| 2024-12-31 | ₩1955.27 | ₩4060.00 | x |
| 2025-12-31 | ₩2789.48 | ₩4060.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently UBcare. Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 26.12%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 18.70%
- • Asset Turnover: 0.87x
- • Equity Multiplier: 1.61x
- Recent ROE (26.12%) is above the historical average (6.38%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 7.64% | 6.36% | 1.00x | 1.20x | ₩-1.11 Billion |
| 2012 | 0.65% | 0.47% | 1.08x | 1.29x | ₩-4.42 Billion |
| 2014 | -6.57% | -3.96% | 1.24x | 1.34x | ₩-6.54 Billion |
| 2015 | 13.70% | 10.44% | 0.93x | 1.42x | ₩1.68 Billion |
| 2016 | 10.89% | 7.43% | 1.05x | 1.39x | ₩413.24 Million |
| 2017 | 7.65% | 4.34% | 1.19x | 1.48x | ₩-1.10 Billion |
| 2018 | 5.67% | 5.77% | 0.77x | 1.28x | ₩-4.40 Billion |
| 2019 | 6.63% | 6.13% | 0.81x | 1.33x | ₩-3.46 Billion |
| 2020 | 5.85% | 5.78% | 0.70x | 1.45x | ₩-4.42 Billion |
| 2021 | 11.29% | 11.91% | 0.75x | 1.27x | ₩1.52 Billion |
| 2022 | 3.07% | 2.69% | 0.82x | 1.39x | ₩-8.08 Billion |
| 2023 | -1.63% | -1.11% | 0.99x | 1.47x | ₩-12.22 Billion |
| 2024 | -1.60% | -0.83% | 1.19x | 1.61x | ₩-11.51 Billion |
| 2025 | 26.12% | 18.70% | 0.87x | 1.61x | ₩22.82 Billion |
Industry Comparison
This section compares UBcare. Co. Ltd's net assets metrics with peer companies in the Software & IT Services industry.
Industry Context
- Industry: Software & IT Services
- Average net assets among peers: $53,607,190,050
- Average return on equity (ROE) among peers: 3.68%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| UBcare. Co. Ltd (032620) | ₩158.89 Billion | 7.64% | 0.43x | $140.04 Million |
| Daishin Information & Communications Co.Ltd (020180) | $28.59 Billion | -0.17% | 1.98x | $32.06 Million |
| PLAYWITH Inc (023770) | $13.65 Billion | 0.00% | 1.50x | $7.73 Million |
| Hancom Inc (030520) | $151.60 Billion | 15.84% | 0.41x | $300.10 Million |
| Softcen Co. Ltd (032680) | $9.15 Billion | 11.19% | 0.68x | $5.97 Million |
| InfoBank Corporation (039290) | $52.41 Billion | 1.60% | 0.39x | $26.52 Million |
| Korea Business News Co. Ltd (039340) | $121.90 Billion | 12.32% | 0.20x | $72.70 Million |
| CUROCOM Co. Ltd (040350) | $51.56 Billion | 0.00% | 0.20x | $54.20 Million |
| Polaris Office Corp (041020) | $37.38 Billion | -26.28% | 0.15x | $125.79 Million |
| Total Soft Bank Ltd (045340) | $16.22 Billion | 18.58% | 0.65x | $38.66 Million |
About UBcare. Co. Ltd
UBcare. Co., Ltd. provides health care solutions in South Korea and internationally. The company offers medical IT services, such as Ysarang, an EMR system for hospital/clinic use; and U Pharm, an integrated management control system for pharmacies, hospitals, clinics, and pharmacy environments; and Big Ysarang, an EMR system for small and medium-sized hospitals, as well as customer management an… Read more